# FDA Inspection 1192725 - Samuel F Hunter, MD - November 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/samuel-f-hunter-md/7a8f271d-35f4-41c1-af8d-7256fce983c6
Source feed: FDA_Inspections

> FDA Inspection 1192725 for Samuel F Hunter, MD on November 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192725
- Company Name: Samuel F Hunter, MD
- Inspection Date: 2022-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 918069 - 2015-02-13](https://www.keypedia.com/records/fda_inspections/samuel-f-hunter-md/1300d538-9a0a-4dc6-abab-bdfecd9b2579)

Company: https://www.keypedia.com/companies/samuel-f-hunter-md/b9a04330-b06b-43a2-a55b-da26a310dd59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c